{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:47:38Z","timestamp":1791920858644,"version":"4.3.4"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,1,2]],"date-time":"2025-01-02T00:00:00Z","timestamp":1735776000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Chemistry"],"DOI":"10.1186\/s13065-024-01374-1","type":"journal-article","created":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T03:42:42Z","timestamp":1735875762000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["A computational approach to drug design for multiple sclerosis via QSPR modeling, chemical graph theory, and multi-criteria decision analysis"],"prefix":"10.1186","volume":"19","author":[{"given":"Fozia Bashir","family":"Farooq","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazeran","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esha","family":"Noor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouf Abdulrahman","family":"Alqahtani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,2]]},"reference":[{"issue":"2","key":"1374_CR1","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, Cohen JA. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"issue":"1","key":"1374_CR2","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","volume":"122","author":"GA Schumacher","year":"1965","unstructured":"Schumacher GA, Beebe G, Kibler RF, Kurland LT, Kurtzke JF, McDowell F, Willmon TL. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122(1):552\u201368.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1374_CR3","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC, Tourtellotte WW. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 1983;13(3):227\u201331.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"1","key":"1374_CR4","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ana.1032","volume":"50","author":"WI McDonald","year":"2001","unstructured":"McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, Wolinsky JS. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 2001;50(1):121\u20137.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"6","key":"1374_CR5","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1002\/ana.20703","volume":"58","author":"CH Polman","year":"2005","unstructured":"Polman CH, Reingold SC, Edan G, Filippi M, Hartung HP, Kappos L, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2005 revisions to the McDonald Criteria. Annals Neurology: Official J Am Neurol Association Child Neurol Soc. 2005;58(6):840\u20136.","journal-title":"Annals Neurology: Official J Am Neurol Association Child Neurol Soc"},{"issue":"2","key":"1374_CR6","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B, Clanet M, Cohen JA, Filippi M, Wolinsky JS. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011;69(2):292\u2013302.","journal-title":"Ann Neurol"},{"issue":"10076","key":"1374_CR7","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/S0140-6736(16)30959-X","volume":"389","author":"WJ Brownlee","year":"2017","unstructured":"Brownlee WJ, Hardy TA, Fazekas F, Miller DH. Diagnosis of multiple sclerosis: progress and challenges. Lancet. 2017;389(10076):1336\u201346.","journal-title":"Lancet"},{"issue":"3","key":"1374_CR8","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/S1474-4422(15)00393-2","volume":"15","author":"M Filippi","year":"2016","unstructured":"Filippi M, Rocca MA, Ciccarelli O, De Stefano N, Evangelou N, Kappos L, Barkhof F. MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines. Lancet Neurol. 2016;15(3):292\u2013303.","journal-title":"Lancet Neurol"},{"issue":"5","key":"1374_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S1474-4422(05)70071-5","volume":"4","author":"D Miller","year":"2005","unstructured":"Miller D, Barkhof F, Montalban X, Thompson A, Filippi M. Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis. Lancet Neurol. 2005;4(5):281\u20138.","journal-title":"Lancet Neurol"},{"issue":"4","key":"1374_CR10","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/0009-2614(72)85099-1","volume":"17","author":"I Gutman","year":"1972","unstructured":"Gutman I, Trinajsti\u0107 N. Graph theory and molecular orbitals. Total \u03c6-electron energy of alternant hydrocarbons. Chem Phys Lett. 1972;17(4):535\u20138.","journal-title":"Chem Phys Lett"},{"key":"1374_CR11","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.apm.2018.03.016","volume":"60","author":"S Hayat","year":"2018","unstructured":"Hayat S, Wang S, Liu JB. Valency-based topological descriptors of chemical networks and their applications. Appl Math Model. 2018;60:164\u201378.","journal-title":"Appl Math Model"},{"key":"1374_CR12","doi-asserted-by":"publisher","first-page":"32276","DOI":"10.1109\/ACCESS.2019.2900500","volume":"7","author":"S Hayat","year":"2019","unstructured":"Hayat S, Imran M, Liu JB. An efficient computational technique for degree and distance based topological descriptors with applications. IEEE Access. 2019;7:32276\u201396.","journal-title":"IEEE Access"},{"issue":"7","key":"1374_CR13","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3390\/pr7070462","volume":"7","author":"S Nasir","year":"2019","unstructured":"Nasir S, Farooq FB, Idrees N, Saif MJ, Saeed F. Topological characterization of nanosheet covered by C3 and C6. Processes. 2019;7(7):462.","journal-title":"Processes"},{"key":"1374_CR14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s10910-010-9677-3","volume":"48","author":"B Furtula","year":"2010","unstructured":"Furtula B, Graovac A, Vuki\u010devi\u0107 D. Augmented Zagreb index. J Math Chem. 2010;48:370\u201380.","journal-title":"J Math Chem"},{"key":"1374_CR15","doi-asserted-by":"crossref","unstructured":"Rehman MA, Shi C, Nazeer W. (2019). Useful irregularity indices in QSPR Study for Bismuth Tri-iodide. J Chem.","DOI":"10.1155\/2019\/2096019"},{"issue":"2","key":"1374_CR16","first-page":"289","volume":"66","author":"M Randi\u0107","year":"1993","unstructured":"Randi\u0107 M. Comparative regression analysis. Regressions based on a single descriptor. Croat Chem Acta. 1993;66(2):289\u2013312.","journal-title":"Croat Chem Acta"},{"issue":"10","key":"1374_CR17","first-page":"1001","volume":"20","author":"M Randic","year":"1996","unstructured":"Randic M. Quantitative structure-property relationship. Boiling points of planar benzenoids. New J Chem. 1996;20(10):1001\u20139.","journal-title":"New J Chem"},{"issue":"01","key":"1374_CR18","doi-asserted-by":"publisher","first-page":"104","DOI":"10.26637\/MJM0801\/0018","volume":"8","author":"MC Shanmukha","year":"2020","unstructured":"Shanmukha MC, Basavarajappa NS, Anilkumar KN. Predicting physico-chemical properties of octane isomers using QSPR approach. Malaya J Matematik. 2020;8(01):104\u201316.","journal-title":"Malaya J Matematik"},{"key":"1374_CR19","doi-asserted-by":"crossref","unstructured":"Hayat S, Imran M, Liu JB. (2019). Correlation between the Estrada index and \u03c0-electronic energies for benzenoid hydrocarbons with applications to boron nanotubes. Int J Quantum Chem, 119(23), e26016.","DOI":"10.1002\/qua.26016"},{"key":"1374_CR20","doi-asserted-by":"crossref","unstructured":"Parveen S, Farooq FB, Awan NUH, Fanja R, Choudhary MF. (2022). Topological indices of drugs used in rheumatoid arthritis treatment and its QSPR modeling. Journal of Mathematics, 2022, 1\u201311.","DOI":"10.1155\/2022\/1562125"},{"issue":"2","key":"1374_CR21","doi-asserted-by":"publisher","first-page":"361","DOI":"10.18576\/jsap\/060211","volume":"6","author":"S Hosamani","year":"2017","unstructured":"Hosamani S, Perigidad D, Jamagoud S, Maled Y, Gavade S. QSPR analysis of certain degree based topological indices. J Stat Appl Probab. 2017;6(2):361\u201371.","journal-title":"J Stat Appl Probab"},{"key":"1374_CR22","unstructured":"Johnson MA, Maggiora GM. (1990). Concepts and applications of molecular similarity."},{"issue":"4","key":"1374_CR23","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2174\/157340907782799381","volume":"3","author":"T Arodz","year":"2007","unstructured":"Arodz T, Dudek AZ. Multivariate modeling and analysis in drug discovery. Curr Comput-Aided Drug Design. 2007;3(4):240\u20137.","journal-title":"Curr Comput-Aided Drug Design"},{"key":"1374_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s40262-018-0695-9","volume":"58","author":"R Hermann","year":"2019","unstructured":"Hermann R, Karlsson MO, Novakovic AM, Terranova N, Fluck M, Munafo A. The clinical pharmacology of cladribine tablets for the treatment of relapsing multiple sclerosis. Clin Pharmacokinet. 2019;58:283\u201397.","journal-title":"Clin Pharmacokinet"},{"issue":"5","key":"1374_CR25","first-page":"1235","volume":"54","author":"CM Kearns","year":"1994","unstructured":"Kearns CM, Blakley RL, Santana VM, Crom WR. Pharmacokinetics of cladribine (2-chlorodeoxyadenosine) in children with acute leukemia. Cancer Res. 1994;54(5):1235\u20139.","journal-title":"Cancer Res"},{"issue":"2","key":"1374_CR26","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2165\/00003088-199732020-00003","volume":"32","author":"J Liliemark","year":"1997","unstructured":"Liliemark J. The clinical pharmacokinetics of cladribine. Clin Pharmacokinet. 1997;32(2):120\u201331.","journal-title":"Clin Pharmacokinet"},{"issue":"1\u20132","key":"1374_CR27","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.jns.2008.06.031","volume":"274","author":"VE Miron","year":"2008","unstructured":"Miron VE, Schubart A, Antel JP. Central nervous system-directed effects of FTY720 (fingolimod). J Neurol Sci. 2008;274(1\u20132):13\u20137.","journal-title":"J Neurol Sci"},{"issue":"2","key":"1374_CR28","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1097\/WNF.0b013e3181cbf825","volume":"33","author":"J Chun","year":"2010","unstructured":"Chun J, Hartung HP. Mechanism of action of oral fingolimod (FTY720) in multiple sclerosis. Clin Neuropharmacol. 2010;33(2):91\u2013101.","journal-title":"Clin Neuropharmacol"},{"key":"1374_CR29","doi-asserted-by":"crossref","unstructured":"Tavares, A., Barret, O., Alagille, D., Morley, T., Papin, C., Maguire, R. P., \u2026 Tamagnan,G. (2014). Brain distribution of MS565, an imaging analogue of siponimod (BAF312), in non-human primates. European Journal of Neurology, 21, 504\u2013504.","DOI":"10.1212\/WNL.82.10_supplement.P1.168"},{"issue":"8","key":"1374_CR30","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1007\/s40265-020-01319-7","volume":"80","author":"YN Lamb","year":"2020","unstructured":"Lamb YN. Ozanimod: first approval. Drugs. 2020;80(8):841\u20138.","journal-title":"Drugs"},{"issue":"9","key":"1374_CR31","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1016\/j.clineuro.2008.03.021","volume":"110","author":"JP Antel","year":"2008","unstructured":"Antel JP, Miron VE. Central nervous system effects of current and emerging multiple sclerosis-directed immuno-therapies. Clin Neurol Neurosurg. 2008;110(9):951\u20137.","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"1374_CR32","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/S1474-4422(14)70264-9","volume":"14","author":"D Ontaneda","year":"2015","unstructured":"Ontaneda D, Fox RJ, Chataway J. Clinical trials in progressive multiple sclerosis: lessons learned and future perspectives. Lancet Neurol. 2015;14(2):208\u201323.","journal-title":"Lancet Neurol"},{"key":"1374_CR33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/j.1749-6632.1988.tb27163.x","volume":"5","author":"JL Carter","year":"1988","unstructured":"Carter JL, Dawson DM, Hafler DA, Fallis RJ, Stazzone LYNN, Orav J, Weiner HL. Cumulative experience with high-dose intravenous cyclophosphamide and ACTH therapy in chronic progressive multiple sclerosis. Ann N Y Acad Sci. 1988;5:535\u20136.","journal-title":"Ann N Y Acad Sci"},{"key":"1374_CR34","first-page":"A148","volume":"60","author":"S Gauthier","year":"2003","unstructured":"Gauthier S, Bharanidharan P, Stazzone L. Treatment of relapsing remitting interferon\/glatiramer acetate unresponsive patients with pulse cyclophosphamide. Neurology. 2003;60:A148.","journal-title":"Neurology"},{"issue":"1","key":"1374_CR35","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1212\/WNL.44.1.16","volume":"44","author":"JH Noseworthy","year":"1994","unstructured":"Noseworthy JH, Ebers GC, Vandervoort MK, Farquhar RE, Yetisir E, Roberts R. The impact of blinding on the results of a randomized, placebo-controlled multiple sclerosis clinical trial. Neurology. 1994;44(1):16\u201316.","journal-title":"Neurology"},{"key":"1374_CR36","first-page":"849","volume":"37A","author":"E Estrada","year":"1998","unstructured":"Estrada E, Torres L, Rodriguez L, Gutman I. An atom-bond connectivity index: modelling the enthalpy of formation of alkanes. Indian J Chem. 1998;37A:849\u201355.","journal-title":"Indian J Chem"},{"key":"1374_CR37","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.dam.2021.04.014","volume":"299","author":"J Rada","year":"2021","unstructured":"Rada J, Rodr\u00edguez JM, Sigarreta JM. General properties on Sombor indices. Discrete Appl Math. 2021;299:87\u201397.","journal-title":"Discrete Appl Math"},{"issue":"2","key":"1374_CR38","first-page":"213","volume":"4","author":"GH Shirdel","year":"2013","unstructured":"Shirdel GH, Rezapour H, Sayadi AM. The hyper-Zagreb index of graph operations. Iran J Math Chem. 2013;4(2):213\u201320.","journal-title":"Iran J Math Chem"},{"issue":"4","key":"1374_CR39","first-page":"116","volume":"1","author":"PS Ranjini","year":"2013","unstructured":"Ranjini PS, Lokesha V, Usha A. Relation between phenylene and hexagonal squeeze using harmonic index. Int J Graph Theory. 2013;1(4):116\u201321.","journal-title":"Int J Graph Theory"},{"issue":"1","key":"1374_CR40","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1021\/ja01280a022","volume":"59","author":"LP Hammett","year":"1937","unstructured":"Hammett LP. The effect of structure upon the reactions of organic compounds. Benzene derivatives. J Am Chem Soc. 1937;59(1):96\u2013103.","journal-title":"J Am Chem Soc"},{"issue":"2","key":"1374_CR41","doi-asserted-by":"publisher","first-page":"206","DOI":"10.2174\/1573409911309020006","volume":"9","author":"V Aguiar-Pulido","year":"2013","unstructured":"Aguiar-Pulido V, Gestal M, Cruz-Monteagudo M, Rabunal JR, Dorado J, Munteanu CR. Evolutionary computation and QSAR research current. Computer-Aided Drug Des. 2013;9(2):206\u201325.","journal-title":"Computer-Aided Drug Des"},{"issue":"3","key":"1374_CR42","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1517\/17460441.2013.748745","volume":"8","author":"J Galvez","year":"2013","unstructured":"Galvez J, Galvez-Llompart M, Zanni R, Garcia-Domenech R. Advances in the molecular modeling and quantitative structure\u2013activity relationship-based design for antihistamines. Expert Opin Drug Discov. 2013;8(3):305\u201317.","journal-title":"Expert Opin Drug Discov"},{"key":"1374_CR43","doi-asserted-by":"crossref","unstructured":"Gleeson, M. P., Modi, S., Bender, A., L Marchese Robinson, R., Kirchmair, J., Promkatkaew,M., \u2026 C Glen, R. (2012). The challenges involved in modeling toxicity data in silico:a review. Current pharmaceutical design, 18(9), 1266\u20131291.","DOI":"10.2174\/138161212799436359"},{"key":"1374_CR44","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.ecoenv.2012.05.013","volume":"82","author":"S Kar","year":"2012","unstructured":"Kar S, Deeb O, Roy K. Development of classification and regression based QSAR models to predict rodent carcinogenic potency using oral slope factor. Ecotoxicol Environ Saf. 2012;82:85\u201395.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"3","key":"1374_CR45","doi-asserted-by":"publisher","first-page":"636","DOI":"10.5740\/jaoacint.SGE_Goodarzi","volume":"95","author":"M Goodarzi","year":"2012","unstructured":"Goodarzi M, Dejaegher B, Heyden YV. Feature selection methods in QSAR studies. J AOAC Int. 2012;95(3):636\u201351.","journal-title":"J AOAC Int"},{"key":"1374_CR46","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-642-48318-9","volume-title":"Multiple attribute decision making: methods and applications","author":"CL Hwang","year":"1981","unstructured":"Hwang CL, Yoon K. Multiple attribute decision making: methods and applications. New York: Springer-; 1981."},{"issue":"3","key":"1374_CR47","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1057\/jors.1987.44","volume":"38","author":"K Yoon","year":"1987","unstructured":"Yoon K. A reconciliation among discrete compromise situations. J Oper Res Soc. 1987;38(3):277\u201386.","journal-title":"J Oper Res Soc"},{"key":"1374_CR48","first-page":"825","volume":"6","author":"F Sari","year":"2018","unstructured":"Sari F. Comparison of TOPSIS and VIKOR multi criteria decision analysis techniques. Sel\u00e7uk \u00dcniversitesi M\u00fchendislik Bilim ve Teknoloji Dergisi. 2018;6:825\u201331.","journal-title":"Sel\u00e7uk \u00dcniversitesi M\u00fchendislik Bilim ve Teknoloji Dergisi"},{"issue":"7","key":"1374_CR49","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1080\/00405000.2018.1541434","volume":"110","author":"Z Chourabi","year":"2018","unstructured":"Chourabi Z, Khedher F, Babay A, Cheikhrouhou M. Multi-criteria decision making in workforce choice using AHP, WSM and WPM. J Text Inst. 2018;110(7):1092\u2013101.","journal-title":"J Text Inst"}],"container-title":["BMC Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13065-024-01374-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13065-024-01374-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,7]],"date-time":"2025-01-07T14:07:48Z","timestamp":1736258868000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcchem.biomedcentral.com\/articles\/10.1186\/s13065-024-01374-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1374"],"URL":"https:\/\/doi.org\/10.1186\/s13065-024-01374-1","relation":{},"ISSN":["2661-801X"],"issn-type":[{"value":"2661-801X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,2]]},"assertion":[{"value":"25 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}}],"article-number":"1"}}